Leukemia Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Completed
- Leukemia
- +3 more
- Bethesda, MarylandNational Cancer Institute (NCI), 9000 Rockville Pike
2022-04-07
Apr 7, 2022N
Completed
- Multiple Myeloma
- +3 more
- Iowa City, Iowa
- +1 more
2022-04-07
Apr 7, 2022N
Recruiting
- Solid Tumor Malignancy
- +4 more
- mRNA-1273
- Bethesda, Maryland
- +1 more
2022-04-07
Apr 7, 2022N
Recruiting
- Glioblastomas
- +4 more
- Enhanced Mindfulness Intervention
- Psychoeducation
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Leukemia
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Not yet recruiting
- Lymphoma
- Leukemia
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Aplastic Anemia
- +3 more
- Cord Blood Units
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022N
Recruiting
- Sickle Cell Disease
- +3 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022N
Completed
- Leukemia
- Berkeley, CaliforniaUniversity of California, Berkeley
2022-04-07
Apr 7, 2022S
Recruiting
- Hodgkin Lymphoma
- +3 more
- Biostrap arm band
- Palo Alto, CaliforniaStanford University
2022-03-29
Mar 29, 2022F
Not yet recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +33 more
- Informational Intervention
- +4 more
- Los Angeles, California
- +4 more
2022-04-04
Apr 4, 2022M
Recruiting
- Hematologic Malignancy
- +4 more
- Automated AI-Guided Diagnosis of Hematological Malignancies
- Munich, Bavaria, GermanyMLL Munich Leukemia Laboratory
2022-04-04
Apr 4, 2022S
Recruiting
- Leukemia
- Lymphoma
- SCRI-CAR22v2
- Los Angeles, California
- +4 more
2022-04-02
Apr 2, 2022S
Recruiting
- Leukemia
- Lymphoma
- Patient-derived CD19- and CD22 specific CAR
- Los Angeles, California
- +4 more
2022-04-02
Apr 2, 2022B
Not yet recruiting
- Leukemia
- IM19 CAR-T cells
- (no location specified)
2022-03-25
Mar 25, 2022C
Recruiting
- Leukemia
- Myelodysplastic Syndrome(MDS)
- Duarte, California
- +1 more
2022-04-01
Apr 1, 2022B
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
- Detroit, MichiganBarbara Ann Karmanos Cancer Institute
2022-03-30
Mar 30, 2022F
Recruiting
- Juvenile Myelomonocytic Leukemia
- +27 more
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- +2 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022C
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
- Birmingham, Alabama
- +42 more
2022-03-22
Mar 22, 2022R
Recruiting
- Pediatric Cancer
- +5 more
- Integrative neuromuscular training (INT)
- +2 more
- Aarhus, Denmark
- +2 more
2022-03-23
Mar 23, 2022N
Terminated
- Leukemia
- +3 more
- rhIL-15
- Obinutuzumab
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-03-11
Mar 11, 2022M
Recruiting
- Solid Tumor
- +3 more
- Phoenix, Arizona
- +8 more
2022-03-21
Mar 21, 2022D
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Leukemia
- Ibrutinib
- +3 more
- Coral Gables, Florida
- +8 more
2022-03-10
Mar 10, 2022M
Withdrawn
- Leukemia
- +2 more
- CAR T-Cell Infusion
- New York, New YorkMemorial Sloan Kettering Cancer Center
2022-03-04
Mar 4, 2022C
Recruiting
- Myelofibrosis
- +13 more
- Phoenix, Arizona
- +54 more
2022-03-04
Mar 4, 2022